Clinical trial
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102
Study timeline
Study start (unknown)2016-06-01Date precision: month
Registry last updated2017-08-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cancer of the Lungunresolved
Lung Cancerunresolved
Lung Neoplasmsunresolved
Adenocarcinoma of the Lungunresolved
Non Small Cell Carcinoma of the Lungunresolved
Small Cell Carcinoma of the Lungunresolved
Interventions
Sponsors & collaborators
Pathway Genomicslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02715102 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.